Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 September-3 October 2024

View source ↗

Summary

PRAC has initiated a safety review of medicines containing finasteride and dutasteride to assess potential safety concerns. The review covers safety implication…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia
• Benign Prostatic Hyperplasia

Drugs mentioned

• DUTASTERIDE (Dutasteride)
• FINASTERIDE (FINASTERIDE)

Snippet

Review of medicines containing finasteride and dutasteride started